drugset / Trial / NCT01965301
First-time-in-man, to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP1.5375
RandomizedParallel-groupDouble-blind
Summary
Phase I Single Ascending Dose (Part 1), phase IIa Proof Of Concept (Part 2)
Timeline
- Start
- 2014-10
- Primary completion
- 2014-10
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BP1.5375 | Unknown | 0.5 mg | Oral |
| Subject | BP1.5375 | Unknown | 100 mg | Oral |
| Subject | Diphenhydramine | Unknown | 50 mg | Oral |
Indications
No indication recorded.